JELD-WEN Holding, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by JELD-WEN Holding, Inc. on May 10, 2021, with the report date reflecting events occurring on May 10, 2021, and the closing of the transaction on May 13, 2021. The filing details a secondary offering of common stock by selling shareholders and a concurrent share repurchase by the Company.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The transaction involved the sale of 10,000,000 shares of common stock by selling shareholders. The Company did not receive any proceeds from this offering. The Company purchased 1,000,000 of the shares from the underwriter at the same price paid by the underwriter to the selling shareholders, resulting in 9,000,000 shares available to the general public.
Material Changes
The primary material event is the execution of an Underwriting Agreement with J.P. Morgan Securities LLC. This resulted in a reduction of the Company's outstanding share count by 1,000,000 shares through the repurchase, while the total number of shares sold in the offering was 10,000,000. The filing text does not provide a clear value for the price per share or the total transaction value.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The transaction was conducted pursuant to a shelf registration statement on Form S-3 effective March 1, 2021. The Underwriting Agreement includes customary representations, warranties, covenants, and indemnification provisions for the underwriter regarding liabilities under the Securities Act of 1933.
Investor Verification Checklist
- Verify the exact price per share paid for the 10,000,000 shares sold and the 1,000,000 shares repurchased, as this figure is not explicitly stated in the summary text.
- Confirm the identity of the "Selling Shareholders" listed in Schedule B of the Underwriting Agreement (Exhibit 1.1).
- Review the final prospectus supplement dated May 10, 2021, for details on the use of proceeds by the selling shareholders.
- Assess the impact of the 1,000,000 share repurchase on the Company's total outstanding share count and earnings per share.